期刊文献+

脂糖肽抗生素Telavancin的合成工艺改进 被引量:4

Process Improvement on the Synthesis of Lipoglycopeptide Antibiotic Telavancin
下载PDF
导出
摘要 以万古霉素盐酸盐为原料,与N-Fmoc-癸基氨基乙醛生成席夫碱后再经还原、脱Fmoc保护、与氨甲基膦酸进行曼尼希反应合成了Telavancin,总收率36.3%,其结构经1H NMR和MS确证。 Telavancin in total yield of 36.3% was synthesized from vancomycin hydrochloride by the reaction with N-Fmoc-decyl-aminoacetaldehyd,followed by reductive amination,deprotection and then Mannich reacted with aminomethylphosphonic acid.The structure was confirmed by 1H NMR and MS.
出处 《合成化学》 CAS CSCD 北大核心 2011年第4期550-553,共4页 Chinese Journal of Synthetic Chemistry
基金 国家"十一五"重大专项关键技术--创新高效合成 国家"十一五"重大专项化药合成平台资助项目
关键词 TELAVANCIN 脂糖肽抗生素 万古霉素 药物合成 工艺改进 Telavancin lipoglycopeptide antibiotic vancomycin drug synthesis process improvement
  • 相关文献

参考文献6

  • 1尚新艳,阮丽军,许激扬,陈代杰.第二代糖肽类抗生素的研究进展[J].中国抗生素杂志,2007,32(5):263-267. 被引量:3
  • 2Lee J. Process for preparing glyeopeptide derivatives CP]. WO 03 018 607,2003.
  • 3Michael R L, Stacy M A, Bettina B, et al. Hydropho- bic bancomycin derivatives with improved ADME prop- erfies: Discovery of telacancin ( TD-6424 ) [J] The Journal of Antibaiotics ,2004,57 (5) : 326 - 336.
  • 4Heinsohn G E. Process for the preparation of phos- phorous acid/carboxylic acid mixed anhydrides and an- hydrous phosphorous acid [ P]. WO 9 513 285,1995.
  • 5Liu Y W, Lee J. Hydroehloride salts of a glyeopetide phosphonate derivative[ P]. US 7 531 623,2005.
  • 6Dudley H W, John R K. Structural and mode of action studies on the antibiotic vancomyein. Evidence from 270-MHz proton magnetic resonance [ J ]. JACS, 1976, 99 (8) :2768 - 2774.

二级参考文献15

  • 1韩亚新,孙欣,杨会军.耐万古霉素肠球菌的耐药机制[J].河北医药,2004,26(8):672-673. 被引量:6
  • 2McCormick M H,Mcguire J M,Pittenger G E,et al.Vancomycin,a new antibiotic,I.Chemical and biologic properties[J].Antibiot Annu,1955 ~ 1956,3:606
  • 3Pootoolal J,Neu J,Wright G D.Glycopeptide antibiotics resistance[J].Annu Rev Pharmacol Toxicol,2002,42:381
  • 4Smith T L,Pearson M L,Wilcox K R,et al.Emergence of vancomycin resistance in Staphylococcus aureus,glycopeptide-intermediate Staphylococcus aureus[J].New Eng J Med,1999,340(7):493
  • 5Barna J C,Williams D H.The structure and mode of action of glycopeptide antibiotics of the vancomycin group[J].Annu Rev Microbiol,1984,38:339
  • 6Allen N E,Letourneao D L,Hobbs J N.The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeotide antibiotics[J].J Antibiot,1997,50(8):677
  • 7Malabarba A,Ciabatti R.Glycopeptide derivatives[J].Curr Med Chem,2001,8 (14):1759
  • 8Allen N E,Nicas T I.Mechanism of action of oritavancin and related glycopeptide antibiotics[J].FEMS Microbiol Rev,2003,26(5):511
  • 9Van Bambeke F.Glycopeptides in clinical development:harmacological profile and clinical perspectives[J].Curr Opin P harmacol,2004,4 (5):471
  • 10Seltzer E,Dorr M B,Goldstein B P,et al.Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections[J].Clin Infect Dis,2003,37(10):1298

共引文献2

同被引文献25

  • 1董玲.氨甲基膦酸的合成[J].南通大学学报(自然科学版),2005,4(2):17-20. 被引量:2
  • 2Nagarajan R, Schabel A A, Occolowitz J L, et al. Synthesis and antibacterial activity of N-acyl vancomycins [ J ]. The Journal of Antibiotics, 1988,41 ( 10 ) : 1430 - 1438.
  • 3Eli Lilly, Company. Urea and thiourea derivatives of glycopeptides[P]. EP 881 230 A2,1998.
  • 4Sehmidt Donald E, Sganga Jeanmarie Donovan. Process for purifying glyeopeptides phosph onate derivatives [P]. US 119 722 A1,2003.
  • 5CHANG MH,KISH TD,FUNG HB.Telavancin:a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults[J].Clin Ther,2010,32(13):2160-2185.
  • 6MENDES RE,SADER HS,FARRELL DJ,et al.Worldwide appraisal and update (2010) of telavancin activity tested against a collection of gram-positive clinical pathogens from five continents[J].Antimicrob Agents Chemother,2012,56(7):3999-4004.
  • 7SARAVOLATZ LD,STEIN GE,JOHNSON LB.Telavancin:a novel lipoglycopeptide[J].Clin Infect Dis,2009,49(12):1908-1914.
  • 8LEE J,LIU J.Process for preparing glycopeptides derivatives:WO,03018607[P].2003-03-06.
  • 9HEINSOHN GE.Process for the preparation of phosphorous acid/carboxylic acid mixed anhydrides and anhydrous phosphorous acid:WO,9513285[P].1995-05-18.
  • 10MICHAEL RL,MARTIN SL.Glycopeptide phosponate derivatives:US,20020022590[P].2002-02-21.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部